PKU 006:: The effect of sapropterin dihydrochloride (tetrahydrobiopterin or 6R-BH4) treatment on phenylalanine (PHE) tolerance in children with phenylketonuria controlled on a PHE-restricted diet

被引：0
|
作者：
Trefz, F.
Burton, B.
Longo, N.
Levy, H.
Bebchuk, J.
Christ-Schmidt, H.
Martinez-Pardo, M.
Gruskin, D.
Dorenbaum, A.
Hennermann, J. B.
机构：
[1] Klin Steinen, Klin Kinder Jugendmed, Reutlingen, Germany
[2] Childrens Mem Hosp, Div Genet, Chicago, IL 60614 USA
[3] Univ Utah, Salt Lake City, UT 84112 USA
[4] Child Hosp Boston, Boston, MA USA
[5] Stat Collab Inc, Washington, DC USA
[6] Hosp Ramon & Cajal, Unidad Enferm Metab, E-28034 Madrid, Spain
[7] Emory Univ, Sch Med, Decatur, GA 30033 USA
[8] Univ Med, Charite, Berlin, Germany
来源：
JOURNAL OF INHERITED METABOLIC DISEASE | 2007年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：17 / 17
页数：1
相关论文
共 8 条
  • [1] Safety and efficacy of a 22-week treatment with sapropterin dihydrochloride (tetrahydrobiopterin or 6R-BH4) in phenylketonuria (PKU)
    Feillet, F.
    Clarcke, L.
    Lee, P.
    Bebchuck, J.
    Meli, C.
    Bergoffen, J.
    Dorenbaum, A.
    Giovannini, M.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 17 - 17
  • [2] Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study
    Levy, Harvey L.
    Milanowski, Andrzej
    Chakrapani, Anupam
    Cleary, Maureen
    Lee, Philip
    Trefz, Friedrich K.
    Whitley, Chester B.
    Feillet, Francois
    Feigenbaum, Annette S.
    Bebchuk, Judith D.
    Christ-Schmidt, Heidi
    Dorenbaum, Alex
    [J]. LANCET, 2007, 370 (9586): : 504 - 510
  • [3] A new case of maternal phenylketonuria treated with sapropterin dihydrochloride (6R-BH4)
    Aldamiz-Echevarri, Luis
    Couce, Maria L.
    Llarena, Marta
    Andrade, Fernando
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (10) : 691 - 693
  • [4] SAPROPTERIN DIHYDROCHLORIDE (6R-BH4) AND MATERNAL PHENYLKETONURIA: TWO CASE STUDIES
    Moseley, K. D.
    Skrabal, J.
    Yano, S.
    Koch, R.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 117 - 117
  • [5] TREATMENT WITH SAPROPTERIN RESULTS IN INCREASED STABILITY OF BLOOD PHENYLALANINE(PHE) LEVELS IN BH4-RESPONSIVE PATIENTS WITH PHENYLKETONURIA (PKU)
    Bausell, H.
    Laduca, H.
    Sullivan, C.
    Katz, R.
    Burton, B. K.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2010, 99 (03) : 209 - 209
  • [6] THE TREATMENT OF PHENYLALANINE HYDROXYLASE (PAH)-DEFICIENT BH4-RESPONSIVE PATIENTS WITH TETRAHYDROBIOPTERIN (BH4): TOLERANCE TO PHE AND RESPONSE TO BH4
    Leuzzi, V.
    Carducci, C.
    De Leo, S.
    Montieri, P.
    Carducci, C.
    Antonozzi, I.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 : 33 - 33
  • [7] Long-term BH4 (sapropterin) treatment of children with hyperphenylalaninemia - effect on median Phe/Tyr ratios
    Tansek, Mojca Zerjav
    Groselj, Urh
    Kelvisar, Matic
    Kobe, Helena
    Lampret, Barbka Repic
    Battelino, Tadej
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2016, 29 (05): : 561 - 566
  • [8] The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin):: a phase II, multicentre, open-label, screening study
    Burton, B. K.
    Grange, D. K.
    Milanowski, A.
    Vockley, G.
    Feillet, F.
    Crombez, E. A.
    Abadie, V.
    Harding, C. O.
    Cederbaum, S.
    Dobbelaere, D.
    Smith, A.
    Dorenbaum, A.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 (05) : 700 - 707
1